- Over 50 APIs in regular production over 15 therapeutic areas.
- 14 Dossiers available for FDFs (including oral and injectable)
- Our key therapeutic areas are:
- We are developing more than 10 new APIs and 15 new FDFs
- We have products in various phases of development
- We have 69 granted patents and 10 patent applications
- Investment in R&D around 14% of our turnover
- Among our pipeline, we can find products from key therapeutic areas:
To know more about our PIPELINE for APIs and FDFs, contact us.